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Abstract
Dental pulp stem cells (DPSCs) from adult teeth express neural crest (NC) markers together with core 
transcriptional factors associated with stem cell pluripotency, such as Oct4a, Sox2, c-Myc, Rex1, Stella/
Dppa3, Ssea1/Fut4, Lin28 and Nanog. The possibility to boost the natural stemness features of DPSCs by mild 
methods, that do not involve gene and/or chromatin modification or gene transfection, is highly desirable for 
cell therapy. Canonical Wnt and Notch are two highly conserved developmental signalling pathways that 
are involved in NC emergence and stem cell self-renewal. We determined that both pathways coordinate 
to regulate the expression of core pluripotency and NC factors in DPSCs. Pharmacological inhibition of the 
Notch pathway for 48 h, by the γ-secretase inhibitor N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine 
t-butyl ester (DAPT), abolished the expression of NC and core factors. In addition, it induced a silencing of 
the canonical Wnt signalling and a clear reduction in the stemness potential of DPSCs, as shown by a reduced 
ability to generate mature, fully differentiated osteoblasts and adipocytes. Conversely, pharmacological 
activation of the Wnt pathway for 48 h, by either the glycogen synthase kinase 3 beta (GSK3-β) inhibitor 
6-bromoindirubin-3´-oxime (BIO) or the human recombinant protein Wnt-3a, not only largely increased the 
expression of NC and core factors, but also increased the efficiency of DPSCs to differentiate into mature 
osteoblasts and adipocytes. These results showed that a short preconditioning activation of Wnt/Notch 
signalling by small molecules and/or recombinant proteins enhanced the stemness and potency of DPSCs in 
culture, which could be useful for optimising the therapeutic use of these and other tissue-specific stem cells.
Keywords: Dental pulp stem cells, multipotency, self-renewal, pluripotency core factors, neural crest, stemness 
and differentiation, osteogenesis, adipogenesis, Notch, Wnt, BIO, DAPT, Wnt-3a.
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Introduction
During embryogenesis, neural crest (NC) cells 
generate most craniomaxillofacial tissues, including 
all major tissues of the teeth, except the enamel. 
The remarkable abilities of the NC prompted 
its designation as “the fourth embryonic layer” 
(Shyamala et al., 2015; Thomas et al., 2008). 
Importantly, some NC stem cells with a non-
differentiated phenotype remain in the dental pulp 
of mature teeth and are known as dental pulp stem 
cells (DPSCs) (Aurrekoetxea et al., 2015; Gronthos et 
al., 2002; Gronthos et al., 2000; Ibarretxe et al., 2012; 
Janebodin et al., 2011; Kaukua et al., 2014; Liu et al., 
2015). Other stem cell types with similar properties 
may be obtained from gingival and periodontal 
tissues (Abe et al., 2012; Huang et al., 2009; Ibarretxe 
et al., 2012; Lima et al., 2017; Liu et al., 2015; Petrovic 
and Stefanovic, 2009) and even from periodontal 
inflammatory lesions, such as human periapical cysts 
(Marrelli et al., 2013; Marrelli et al., 2015; Tatullo et 
al., 2015). Similarly to NC-derived cells, dental stem 
cells are characterised by the expression of neural 
crest factors, such as Snail/Snai1, Slug/Snai2, Twist1, 
Hnk1, Pax3, Neurogenin2 and Sox10 (Kiraly et al., 
2009; Schiraldi et al., 2012), and core factors including 
Oct4a, Sox2, Klf4, Lin28, stage specific embryonic 
antigen 3 antibody (Ssea1) and Nanog (Atari et 
al., 2012; Ferro et al., 2012; Janebodin et al., 2011; 
Kerkis et al., 2006; Rosa et al., 2016). Core factors are 
fundamental in maintaining stem cell pluripotency 
(Chambers and Tomlinson, 2009; Takahashi et al., 
2007; Yu et al., 2007), thus suggesting that dental 
stem cells may present some superior features with 
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respect to other multipotent stem cell populations of 
the adult human body (Atari et al., 2011; Atari et al., 
2012; Rosa et al., 2016). This could be very relevant 
for cell therapy because stem cells from dental tissues 
are known to be easily accessible for extraction and 
well-tolerated upon grafting, due to their immune-
suppressive properties (Pierdomenico et al., 2005). 
Furthermore, DPSCs are non-tumourigenic even after 
their immortalisation by telomerase overexpression 
(Wilson et al., 2015). Finally, given that the dental 
pulp is rather well preserved in mid-to-advanced 
age patients, DPSCs are also suitable for autologous 
therapy (Ibarretxe et al., 2012; Kellner et al., 2014; Wu 
et al., 2015).
 The canonical Notch and Wnt signalling pathways 
are critical for the maintenance of the stem cell 
phenotype (Androutsellis-Theotokis et al., 2006; 
Borghese et al., 2010; Clevers et al., 2014; Perdigoto and 
Bardin, 2013; Reya and Clevers, 2005). Both pathways 
also play an important role in the emergence of the 
NC (Hari et al., 2012; Leung et al., 2016; Rogers et al., 
2012; Stuhlmiller and Garcia-Castro, 2012). Dental 
stem cells present higher levels of core factors and 
Wnt/Notch activity compared to other mesenchymal 
stem cells in the adult body (Atari et al., 2012; Huang 
et al., 2009; Janebodin et al., 2011; Vasanthan et al., 
2015). However, the role of these pathways in the 
maintenance of stemness and self-renewal in DPSCs 
is still unclear.
 Activation of Notch signalling through ligand 
binding triggers the proteolytic cleavage of Notch 
receptors, by a disintegrin and metalloproteases 
(ADAM) followed by γ-secretases, which results in the 
cleavage and release of the Notch intracellular domain 
(NICD) from the membrane. NICD translocates to the 
nucleus where it directly interacts with CSL/RBPj/
CBF-1 transcription factors to turn on the expression 
of Notch target genes, such as the hairy/enhancer 
of split (Hes) family (D’Souza et al., 2010). In the 
canonical Wnt signalling, the interactions between 
Wnt protein ligands and Frizzled/LRP receptors lead 
to the recruitment of axis inhibition protein (AXIN), 
adenomatous polyposis coli (APC) and glycogen 
syntase kinase 3 beta (GSK3-β) to the membrane, 
thus preventing phosphorylation and degradation of 
β-catenin. As a result, β-catenin accumulates in the 
cytoplasm and translocates into the nucleus, where 
it interacts with the T-cell factor/lymphoid enhancer 
factor (TCF/LEF) family factors and leads to the 
expression of Wnt signalling target genes (Clevers, 
2006). Both pathways regulate each other at multiple 
points (Borggrefe et al., 2016; Fukunaga-Kalabis et al., 
2015) and promote the maintenance of self-renewal 
and inhibition of differentiation in many stem cell 
types, including DPSCs (Mizutani et al., 2007; Scheller 
et al., 2008; Yiew et al., 2017).
 Pharmacological manipulation of the Notch and 
Wnt pathways is relatively simple using well-known 
drugs, such as N-[N-(3,5-Difluorophenacetyl)-
L-alanyl]-S-phenylglycine t-butyl ester (DAPT) 
(γ-secretase inhibitor; Notch signalling blocker) and 
BIO (GSK3-β inhibitor; Wnt signalling activator), 
and recombinant activator proteins, such as Wnt-3a. 
The use of BIO and DAPT has already proven to be 
a valuable complementary strategy to induce either 
cellular reprogramming or cellular differentiation 
(Ichida et al., 2014; Kitajima et al., 2016). Therefore, 
a thorough understanding of the stemness and 
differentiation potential of DPSCs and their 
modulation by cell signalling pathways would be 
highly desirable to use these cells more efficiently 
in areas such as regenerative medicine, tissue 
engineering and drug screening. In this work, we 
used DAPT and BIO, as well as human recombinant 
Wnt-3a, as pharmacological modulators to investigate 
the role of Notch/Wnt in maintaining the stemness 
and expression of pluripotency core factors in DPSCs, 
with the goal of optimising existing protocols for 
differentiation to somatic cells.
Materials and Methods
DPSC culture
DPSCs were isolated from human third molars 
obtained from healthy donors between 15 and 
30 years of age. The pulp tissue was isolated by 
fracture and enzymatic digestion for 1 h at 37 °C 
with 3 mg/mL collagenase (17018-029; Thermo Fisher 
Scientific, Boston, MA, USA) and 4 mg/mL dispase 
(17105-041; Thermo Fisher Scientific) followed by 
mechanical dissociation. DPSCs were cultured in 
Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10 % foetal bovine serum (FBS), 
1 mM L-glutamine, 100 U/mL penicillin and 150 µg/
mL streptomycin. DPSCs could be amplified and 
maintained in these conditions for a very long time 
(> 6 months). However, to avoid cell aging issues, 
only DPSCs that had been grown in culture for less 
than 3 months and had accumulated no more than 6 
total passages were used. Comparative experiments 
between control and treatment conditions were 
always and without exception performed in parallel 
using DPSCs from the same donor.
Notch and Wnt pathway pharmacological 
modulation
To block Notch signalling, 2.5 µM  DAPT γ-secretase 
inhibitor (565784; Calbiochem, San Diego, CA, 
USA) was added to the culture medium 48 h prior 
to the assays, where DAPT-treated DPSCs were 
compared to DPSCs treated only with the control 
vehicle dimethyl sulfoxide (DMSO). To overactivate 
Wnt signalling, 2.5 µM 6-bromoindirubin-3´-oxime 
(BIO), a GSK3-β inhibitor (361550; Calbiochem), 
was used, which was added to the medium 48 h 
prior to the assays. BIO-treated cells were compared 
to DPSCs exposed to 2.5 µM inactive analogue 
methyl-6-bromoindirubin-3´-oxime (MBIO) (361556; 
Calbiochem). Wnt-3a recombinant protein (5036-










Gapdh Upstream CTTTTGCGTCGCCAG 60.3 131Downstream TTGATGGCAACAATATCCAC 60.8
Notch1 Upstream ATAGTCTGCCACGCC 54 149Downstream AGTGTGAAGCGGCCA 54.9
Notch2 Upstream AAGCCCAGACATTCTTGCAGCTTG 64.1 107Downstream TCCAGGGCATAATTCCCAACAGGA 63.7
Notch3 Upstream ACCCCCAAGAGGCAAGTGT 61.1 125Downstream AGGATGAAAAAGACTAAAAGGAAGGAA 59
Notch4 Upstream GCGATAATGCGAGGAAGATACG 59.4 118Downstream TCGGAATGTTGGAGGCAGAAC 60.6




Nestin Upstream GGTCCTAGGGAATTGCAGC 57.9 144Downstream CTCAAGATGTCCCTCAGCCT 58.8
Jagged1 Upstream AGATCTCAATTACTGTGGGAC 57.1 88Downstream GCAGGAACACTGATATTTGTC 58.7
Jagged2 Upstream TCTTGCAAAAACCTGATTGG 62.6 86Downstream CAGTCGTTGACGTTGATATG 59.2
Lef1 Upstream TGCCAAATATGAATTAACGACCCA 59 151Downstream GAGAAAAGTGCTCGTCACTGT 58.5
Oct4* Upstream CGTGAAGCTGGAGAAGGAGA 60.7 137Downstream CATCGGCCTGTGTATATCCC 60.1
c-Myc Upstream GTCAAGAGGCGAACACACAAC 60 162Downstream TTGGACGGACAGGATGTATGC 60.1
Sox2 Upstream ATAATAACAATCATCGGCGG 61.1 90Downstream AAAAAGAGAGAGGCAAACTG 57.8
Klf4 Upstream TCTTGAGGAAGTGCTGAG 56.5 147Downstream ATGAGCTCTTGGTAATGGAG 58.3
Table 1a. Primer pairs used. * transcript variants (Pou5f1, Oct4a and Pou5f1p1, Oct4pg1).
WN-010; R&D Systems, Minneapolis, MN, USA) was 
added to the DPSCs cultures to overactivate Wnt 
signalling at two concentrations: 2.5 µM and 5 µM.
Osteogenic differentiation of DPSCs
The following protocol was used to induce 
DPSC differentiation to mature osteoblasts: 6 µM 
β-glicerophosphate (G9422; Sigma-Aldrich, St. 
Louis, MA, USA), 10 nM dexamethasone (D4902; 
Sigma-Aldrich) and 52 nM ascorbic acid (127.0250; 
Merck, Darmstadt, Germany) were added to 
the cells cultured in DMEM + 10 % FBS for three 
weeks. The DPSCs had been previously subjected 
to preconditioning treatment with DMSO, DAPT, 
MBIO or BIO for 48 h, as described. Terminal 
osteoblast differentiation was assessed by detection 
of extracellular calcified bone matrix deposits by 
Alizarin Red S staining using 2 g/100 mL Alizarin 
Red S (400480250; Across Organics, Geel, Belgium) 
at pH 4.3. The DPSCs were fixed with 10 % formalin 
(F7503; Sigma-Aldrich) for 30 min. Then, cells were 
incubated with Alizarin Red S for 45 min before 
being washed four times with PBS to remove any 
background staining. The Alizarin Red S absorbance 
at 450 nm was quantified using a Synergy HT Multi-
Mode Microplate Reader (BioTek, Winooski, VT, 
USA). Also, alkaline phosphatase (ALP) staining 
was used to assess osteoblast differentiation, as 
this enzymatic activity is present in mature bone 
matrix-secreting cells. One SIGMA FAST™ BCIP/
NBT (5-bromo-4-chloro-3-indolyl phosphate/nitro 
blue tetrazolium) tablet (B5655-5ATB; Sigma-Aldrich) 
was dissolved in 10 mL milliQ water and added to 
the DPSCs fixed for 1 min with 10 % formalin. Next, 
cells were washed with PBS containing 0.05 % Tween 
20 (STBB3609; Sigma-Aldrich). ALP activity was 
quantified by measuring the absorbance at 405 nm 
with a Synergy HT Multi-Mode Microplate Reader 
(BioTek).
Adipogenic differentiation of DPSCs
To induce adipogenic differentiation, DPSC 
cultures were treated with 0.5 mM 3-Isobutyl-1-
methylxanthine (IBMX) (I5879; Sigma-Aldrich), 
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1 µg/mL insulin (91077C; SAFC Biosciences, St. 
Louis, MA, USA) and 1 µM dexamethasone (D4902; 
Sigma-Aldrich) for four weeks after a preconditioning 
treatment with DMSO, DAPT, MBIO or BIO for 48 h. 
Subsequently, DPSCs were fixed with 10 % formalin 
for 10 min and then washed with PBS containing 60 % 
isopropanol. Lipid droplets in mature adipocytes 
were detected using Oil Red O staining solution, 
which contained 5.14 µM Oil Red O stock (O-0625; 
Sigma-Aldrich) diluted in milliQ water. Cells were 
stained for 10 min and the Oil Red O absorbance was 
measured at 490 nm using a Synergy HT Multi-Mode 
Microplate Reader (BioTek).
RNA extraction, conventional RT-PCR and 
quantitative Real-Time PCR (qPCR)
Cell pellets were frozen and stored at -80 °C. Total 
RNA was extracted from the cells using the RNeasy 
kit (74104; Qiagen, Hilden, Germany) and purity was 
checked by calculating the 260/280 absorbance ratio 
using the Nanodrop Synergy HT (BioTek). cDNA 
(50 ng/µL) was obtained by reverse transcription 
of total extracted RNA using the iScript cDNA kit 
(1708890; BioRad, Hercules, CA, USA) with the 
following reagents: iScript Reverse Transcriptase 
(1 µL), 5× iScript Reaction Mix (4 µL) and Nuclease-
free water (variable) to a final volume of 20 µL. 
Gene expression was analysed using 1 µL of cDNA 
(5 ng/µL) diluted in 4 µL of My TaqTM Red Mix 
(BIO-25043, Bioline, St. Petersburg, Russia), 1 µL of 
primers (0.625 µM) and Nuclease Free Water, for a 
total volume reaction of 10 µL for a conventional 
RT-PCR. Amplification products were separated 
by electrophoresis in a 2 % agarose gel. qPCR 
experiments were conducted in an iCyclerMyiQTM 
Single-Color Real-Time PCR Detection System 
(BioRad) using 4.5 µL of Power SYBR® Green PCR 
Master Mix 2× (4367659; Applied Biosystems™ 
Applied Biosystems, Carlsbad, CA, USA), 0.5 µL 
of primers (0.3125 µM), 0.3 µL of cDNA (1.5 ng/µL) 
and Nuclease Free water for a total volume reaction 
of 10 µL. All primers were obtained from public 
databases and checked for optimal efficiency (> 90 %) 
under our qPCR experimental conditions. The 
relative expression of each gene was calculated using 
the standard 2-ΔΔCt method (Livak and Schmittgen, 
2001) and normalised to the average between β-actin 
and Gapdh, as internal controls. All reactions were 






Nanog Upstream GTCAAGAAACAGAAGACCAG 56.4 184
Downstream GCCACCTCTTAGATTTCATTC 59.2
Lin28 Upstream CTGGTGGAGTATTCTGTATTG 56.2 81
Downstream ACCTGTCTCCTTTTGATCTG 58.3
Rex1 Upstream TATCTCAACCTGTTCATCGAG 59.3 130
Downstream CCACATTCAGGTAGATGTTC 56.9
Ssea1/Fut4 Upstream ACAAAATCATCTGTTGGGAC 58.9 85
Downstream AGCAGATAAGCACTTTCAAC 56.2
Stella/Dppa3 Upstream GAGGAGTAAGAACATTGCTG 56.5 133
Downstream CTTGATTCCTTCTTAACTCCC 58.3
Snail/Snai1 Upstream AACAATGTCTGAAAAGGGAC 58.1 94
Downstream ATAGTTCTGGGAGACACATC 55.4
Slug/Snai2 Upstream AAACAACCTGAAGACTTGTG 56.8 157
Downstream TTCTTTGTACAGTGGTTTGG 57.7
Sox10 Upstream ACTTAGTGGAGTTCTCATCC 54.7 106
Downstream AAGAATGAGGTTATTGGCAC 58.1
Pax3 Upstream ATCAACTGATGGCTTTCAAC 59.2 120
Downstream CAGCTTGTGGAATAGATGTG 58.3
Pax7 Upstream AGGAGTACAAGAGGGAAAAC 56.4 108
Downstream TAATCGAACTCACTGAGGG 57.8
Neurogenin2 Upstream AGGGAAGAGGACGTGTTAGTGC 61.9 225
Downstream GCAATCGTGTACCAGACCCAG 61
Twist1 Upstream CTAGATGTCATTGTTTCCAGAG 57.9 136
Downstream CCCTGTTTCTTTGAATTTGG 60.9
Wnt3 Upstream CTGTGACTCGCATCATAAG 56.8 186
Downstream ATGTGGTCCAGGATAGTC 54.3
Wnt1 Upstream CTATTTATTGTGCTGGGTCC 58.5 125
Downstream AGAAACTGAGGAGAGAAGAG 54.2
Hnk1 Upstream TGTGAGTGCTGGTAATGAG 57.2 169
Downstream ACTGCCCTCATCCTTATG 57.5
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performed in triplicate. qPCR was run on an ABI 
PRISM® 7000 (Thermo Fisher Scientific). Data were 
processed by CFX Manager™ software (BioRad). We 
assessed that all qPCR reactions yielded only one 
amplification product by the melting curve method. 
Primer pairs used were obtained through the Primer-
Blast method (Primer Bank) and they are listed in 
Table 1a,b.
Protein extraction
Cells were washed several times with 0.9 % NaCl 
and the proteins were extracted with 100 µL of lysis 
buffer [50 mM Tris-HCl pH 7.5, 1 mM EDTA, 150 mM 
NaCl, 0.5 % sodium deoxycholate, 0.1 % SDS, 1 % 
IGEPAL® CA-630 in dH2O and 1 : 100 Proteinase 
Inhibition Cocktail Set III (539134; Calbiochem)]. 
Protein quantification was performed before each 
Western Blot (WB) using the DCTM Protein Assay 
(5000112; Bio Rad).
Western Blot (WB)
Samples were diluted in NuPAGE sample buffer 
(NP0007; Novex, Life technologies, Carlsbad, 
CA, USA) and loaded onto a 4-12 % Invitrogen 
NuPAGE BisTris Gel (1 mm × 10 wells; NP032180X, 
Novex, Life Technologies). Subsequently, they 
were transferred onto 0.45 µm-pore nitrocellulose 
membranes (Inmmobilon® Transfer Membranes; 
Millipore, St. Charles, MO, USA) using a XCell Sure 
Lock Electrophoresis machine (NP0007; Novex, 
Life Technologies). For WB analyses, the following 
antibodies were used: 1 : 1000 rabbit anti β-actin 
(4967; Cell Signaling Technology (CST), Danvers, 
MA, USA), 1 : 10000 mouse anti-Gapdh (MAB374; 
Millipore), 1 : 2000 rabbit anti-PARP (9542S; CST), 
1 : 500 rabbit anti-Sox2 (GTX101506; GeneTex, Irvine, 
CA, USA), 1 : 1000 rabbit anti-Nanog 1,2 (D73G4; CST, 
1 : 1000 rabbit anti-Notch 1-receptor intracellular 
domain (N1ICD) (ab8925; Abcam, Cambridge, UK), 
1 : 4000 rabbit anti-total β-catenin (ab6302; Abcam) 
and 1 : 500 mouse anti-active β-catenin (05-665; 
Millipore). The secondary antibodies (P0260; DAKO, 
Hovedstaden, Denmark; NA9340, GE Healthcare, 
Amersham, UK) were used at a 1 : 2000 dilution. The 
membranes were stripped using Red Blot reagent 
(M2504; Inmmobilon® EMD, Millipore).
Immunofluorescence (IF)
DPSCs cultured on glass coverslips were fixed with 
4 % paraformaldehyde for 10 min and washed with 
PBS. Blocking was performed by 10 min incubation 
with Normal Goat Serum (501972; Thermo Fisher 
Scientific). Next, DPSCs were incubated overnight 
at 4 °C with primary antibodies diluted in PBS + 2 % 
BSA + 0.1 % Triton X-100. The rabbit anti-N1ICD 
(ab8925; Abcam), anti-Oct4 (ab19857; Abcam), anti-
c-Myc (ab32[9E10]; Abcam), anti-Ki67 (ab15580; 
Abcam) and anti-total β-catenin (ab6302; Abcam) 
antibodies were used at 1 : 200, 1 : 100, 1 : 1000, 1 : 100 
and 1 : 3000 dilutions, respectively. Goat anti-rabbit 
Alexa Fluor (488: A11012; 594: A11012; Invitrogen, 
Carlsbad, CA, USA) were employed as secondary 
antibodies at a 1 : 200 dilution, followed by DAPI, 
used to counterstain cell nuclei. Images were captured 
with an epifluorescence ZEISS Axioskop (ZEISS, Jena, 
Germany) operated with Nikon NIS-Elements and an 
Apotome Confocal Microscope (ZEISS) operated with 
Nikon DS-Qi1Mc software (Nikon, Tokyo, Japan). 
Samples fluorescence intensities were quantified by 
Fiji-ImageJ (Schindelin et al., 2012) after background 
subtraction.
Cell proliferation and death assays
20 µg/mL propidium iodide (PI; Sigma-Aldrich) was 
used to detect cell death and 5 µM calcein-AM (Life 
Technologies) to detect cell viability. Both fluorescent 
dyes were incubated for 30 min at 37 °C in culture 
medium and subsequently cells were washed 3 times 
with PBS. Fluorescence quantification was calculated 
by microfluorimetry, measuring light emission at 
495 nm (calcein-AM: green fluorescence) and 630 nm 
(PI: red fluorescence) in a Fluoroskan Ascent plate 
reader (Thermo Fisher Scientific).
Statistical analyses
Statistical analyses were performed with Excel, IBM 
SPSS Statistics v.9 (SPSS, Chicago, IL, USA) and 
GrapH Pad v.6 software (Graph Pad Inc., La Jolla, CA, 
USA). All data sets were subjected to a Kolmogorov-
Smirnov normality test prior to analysis. For small 
sample sizes, non-parametric tests were chosen by 
default. Comparisons between only two groups were 
made using U-Mann Whitney test. Comparisons 
between multiple groups were made using Kruskal-
Wallis followed by Dunn´s post hoc test. p ≤ 0.05 was 
considered to be statistically significant.
Results
Notch activity was required for the expression 
of core pluripotency factors and self-renewal of 
DPSCs
Control DPSCs showed detectable amounts of 
core pluripotency factors, such as Oct4 (Pou5f1 and 
Pou5f1p1), Sox2, Nanog, Lin28, Rex1, Stella, Ssea1 and 
c-Myc, measured by RT-PCR amplicon bands. To 
assess whether DAPT treatment would affect the 
expression of core factors in DPSCs, we exposed the 
DPSC cultures to transient applications of 2.5 µM 
DAPT for 48 h. Interestingly, for many of these 
factors, the RT-PCR bands were significantly reduced 
or lost when the DPSCs were treated with DAPT (Fig. 
1a). As an internal control to assess Notch activity, 
we examined the expression of the Notch target 
gene Hes1. A clear decrease in Hes1 expression was 
consistently observed following DAPT treatment. 
Next, these changes were validated by qPCR, 
confirming that all core factors had significantly 
decreased levels of expression when DPSCs were 
exposed to DAPT. In some cases, such as that of 
Rex1 or Ssea1 expression, the decrease in expression 
254 www.ecmjournal.org
V Uribe-Etxebarria et al.                                                                     Notch/Wnt crosstalk regulates DPSC stemness
Fig. 1. Notch inhibition by DAPT reduced the expression of core pluripotency factors in DPSCs. (a) RT-
PCR revealed differences in the expression of c-Myc, Sox2, Nanog, Oct4a and Hes1 expression following 
DAPT exposure. (b) qPCR analysis confirmed a decrease in c-Myc, Sox2, Nanog, Oct4a, Rex1, Stella, 
Ssea1 and Hes1 transcripts between the control (DMSO) and DAPT conditions. Data were normalised to 
reference β-actin and Gapdh levels and presented as the mean + SEM (n = 3). The dashed line represented 
normalised gene expression in control conditions. (c-h) IF images of DPSCs grown for 48 h in presence 
or absence of DAPT and stained for (c,d) Oct4, (e,f) c-Myc and (g,h) N1ICD (in green). DAPI labelled 
cell nuclei (in blue). Scale bar = 20 µm. (i,j,m) Bar charts showing relative total and nuclear (i) Oct4, (j) 
c-Myc and (m) N1ICD fluorescence in control and DAPT-treated DPSCs. The data are presented as mean 
+ SEM (n = 3). Representative WB showing (k) Sox2, Nanog and (l) active cleaved N1ICD. β-actin was 
used as protein loading control. * p < 0.05, ** p < 0.01, *** p < 0.001. U-Mann Whitney test.
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was more than 90 % with respect to control (Fig. 1b). 
Finally, these changes were also corroborated by IF 
and WB, where Oct4 (nuclear active form Oct4-a; 
Atlasi et al., 2008; Ferro et al., 2012; Liedtke et al., 
2007), Sox2, Nanog (canonical isoform 1; Saunders et 
al., 2013; Wang et al., 2008), c-Myc and Notch activity 
marker N1ICD, had also a consistently reduced 
expression at the protein level (Fig. 1c-l).
 The proliferation rates of DPSCs in the presence 
or absence of DAPT were compared, to verify if the 
decreased expression of core factors in DPSCs also 
reflected a decreased ability for self-renewal and 
proliferation. DPSCs were incubated with a mixture 
of calcein-AM/PI, after being cultivated for 48 h in 
the presence or absence of DAPT.  No PI fluorescence 
was detectable in either condition, indicating that cell 
viability was not compromised by DAPT treatment. 
However, calcein fluorescence was reduced by 
approximately 40 % in the DAPT conditions 
compared to control (Fig. 2a-c). To corroborate this 
result, the number of proliferative cells positive for 
Ki67, a marker of cell proliferation present during the 
G1, S, G2 and M phases of the cell cycle, but absent 
from non-dividing cells (G0), was evaluated. Ki67 
labelling was significantly lower in the DAPT-treated 
DPSCs with respect to controls, thus indicating a 
reduction in the amount of cycling proliferative cells 
(Fig. 2e-g). Finally, it was confirmed that, despite 
inducing a reduction in DPSC proliferation, DAPT 
treatment did not cause any genomic damage or 
apoptotic cell death. The cleaved poly-ADP ribose 
polymerase (PARP) levels were assessed by WB 
and resulted negative in all conditions (Fig. 2d). 
Taken together, these results suggested that Notch 
inhibition caused a decrease in the expression of core 
pluripotency factors in DPSCs, which resulted in 
decreased self-renewal and proliferation capacities, 
without affecting cell viability.
Notch and Wnt/β-catenin signalling interacted 
and positively regulated each other in DPSCs
To assess whether Notch signalling interacted with 
Wnt/β-catenin signalling in DPSCs, the effect of 
DAPT treatment on the expression of Wnt signalling 
Fig. 2. Cell proliferation and cell death analysis in DPSCs exposed to DAPT. (a,b) Calcein-AM (green) 
and PI (red) staining of DPSCs grown in control and DAPT for 48 h. Scale bar = 200 µm. (c) Quantification 
of relative calcein-AM and PI fluorescence. Data are presented as mean + SEM (n = 7). (d) WB showing 
absence of cleaved PARP protein (89 kDa; red arrow) in both DMSO and DAPT conditions in comparison 
with total inactive non-cleaved PARP (116 kDa), which was well detected. (e,f) IF for Ki67 in DMSO and 
DAPT conditions. Scale bar = 20 µm. (g) Quantification of Ki67 labelling in DAPT-treated and control 
DPSCs. Data are presented as mean + SEM (n = 7). ** p < 0.01, *** p < 0.001. U-Mann Whitney test.
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Fig. 3. Notch inhibition by DAPT negatively regulated Wnt/β-catenin signalling in DPSCs. (a) RT-PCR 
revealed differences in the expression of key Wnt signalling mediators and targets Wnt-3a, β-catenin and 
Lef1 in DPSCs following DAPT exposure. (b) qPCR confirmed a decrease in both Notch receptors and 
Wnt factors between control (DMSO) and DAPT conditions. Data were normalised to β-actin and Gapdh 
levels and presented as the mean + SEM (n = 4). The dashed line represented normalised gene expression 
in control conditions. (c,d) IF images of total β-catenin in DAPT-treated DPSCs compared with controls. 
Scale bar = 20 µm. (e) Bar chart showing relative total and nuclear β-catenin fluorescence in control and 
DAPT conditions. (f) WB of total and nuclear active β-catenin in control and DAPT-treated DPSCs. 
β-actin was used as a protein loading control. * p < 0.05, ** p < 0.01, *** p < 0.001. U-Mann Whitney test.
targets genes was studied by qPCR. Notch1-4 receptor 
expression was negatively affected by the treatment, 
whereas the expression of the Notch ligand Jagged1 
was unaffected (Fig. 3a,b). These results showed 
an overall downregulation of Notch signalling in 
DPSCs induced by DAPT treatment. Intriguingly, 
we also found out that DAPT treatment reduced the 
expression of the canonical Wnt mediators Wnt-3a 
and β-catenin and also that of the Wnt target gene 
Lef1 by ~50-70 % compared to their respective control 
values (Fig. 3a,b). To confirm this result, β-catenin 
protein levels were assessed both by WB and IF. 
A significant decrease in the amount of both total 
and nuclear active β-catenin was found in DPSCs 
exposed to DAPT for 48 h (Fig. 3c-f). Therefore, 
Notch inhibition resulted in a parallel Wnt/β-catenin 
signalling inhibition in DPSCs.
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Fig.4. Wnt activation by BIO led to increased expression of core pluripotency factors in DPSCs. (a) RT-PCR 
revealed differences in the expression of c-Myc, Sox2, Nanog, Oct4 and Lef1 following BIO exposure. (b) 
qPCR analysis confirmed an increase in c-Myc, Sox2, Nanog, Oct4a, Rex1, Stella, Ssea1 and Lef1 expression 
between control (MBIO) and BIO conditions. Data were normalised to β-actin and Gapdh levels and 
presented as the mean + SEM (n = 3). The dashed line represented normalised gene expression in control 
conditions. (c-h) IF images of DPSCs grown in the presence of MBIO or BIO for 48 h and stained for 
(c,d) Oct4, (e,f) c-Myc and (g,h) total β-catenin. DAPI labelled nuclei in blue. Scale bar = 20 µm. (i,j,m) 
Bar charts showing relative total and nuclear (i) Oct4 (j) c-Myc and (m) total β-catenin fluorescence in 
MBIO and BIO-treated DPSCs. Data are presented as the mean + SEM (n = 3). (k,l) Representative WB 
showing an increase in (k) Sox2, native Nanog1 and Nanog2 isoforms, with slightly different molecular 
weights, and (l) in both total β-catenin and active β-catenin protein expression. β-actin was used as a 
protein loading control. * p < 0.05, ** p < 0.01, *** p < 0.001. U-Mann Whitney test.
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BIO-induced Wnt activation enhanced the 
expression of pluripotency core factors in DPSCs
To investigate whether Wnt/β-catenin activation 
would enhance the expression of pluripotency 
core factors in DPSCs, we used BIO treatment for 
48 h to hyperactivate Wnt signalling by inhibiting 
β-catenin degradation. As a control for treatment 
efficacy, BIO-treated DPSCs showed increased levels 
of both total and active β-catenin protein, whereas 
other Wnt targets, such as Lef1, also demonstrated 
consistently increased expression (Fig. 4a,b,g,h,k-l). 
Therefore, BIO induced a strong hyperactivation of 
Wnt signalling in DPSCs. Then, the expression of 
pluripotency core factors in BIO-treated DPSCs by 
RT-PCR and qPCR was assessed. It was determined 
that BIO also induced overexpression of pluripotency 
factors at both the transcript (Fig. 4a,b) and protein 
levels (Fig. 4c-k).
 In addition to boosting the expression of 
core pluripotency factors, BIO increased the 
proliferation ability of DPSCs. As shown by the 
calcein/PI assay, the number of viable cells in culture 
significantly increased after BIO treatment (Fig. 5a-
c). Consistently, the Ki67/DAPI fluorescence ratio 
increased in response to BIO treatment, indicating a 
greater proportion of active dividing cells (Fig. 5e-g). 
Neither PI-positive cells nor an active PARP signal in 
BIO-treated cells were detected (Fig. 5d). Together, 
these experiments demonstrated that Wnt activation 
by BIO treatment increased the proliferation and self-
renewal capacities of DPSCs without compromising 
their viability and genomic integrity.
Wnt activation by BIO induced Notch 
upregulation in DPSCs
Given that DAPT treatment affected Wnt signalling 
in DPSCs, the question whether Notch activity 
would also be affected in BIO-treated DPSCs needed 
addressing. It was found that in BIO-treated DPSCs, 
most Notch receptors did not undergo any change 
Fig. 5. Cell proliferation and cell death analysis in DPSCs exposed to BIO. (a,b) Calcein-AM (green) and PI 
(red) staining of DPSCs grown in MBIO and BIO conditions for 48 h. Scale bar = 200 µm. (c) Quantification 
of relative calcein-AM and PI fluorescence. Data are presented as mean + SEM (n = 7). (d) WB showing 
absence of cleaved PARP protein (89 kDa; red arrow) in both MBIO and BIO conditions, in comparison 
with total inactive non-cleaved PARP (116 kDa), which was well detected. (e,f) IF for Ki67 in MBIO and 
BIO conditions. Scale bar = 20 µm. (g) Quantification of Ki67 labelling in MBIO- and BIO-treated DPSCs. 
Data are presented as mean + SEM (n = 7). * p < 0.05. U-Mann Whitney test.
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Fig. 6. Wnt activation by BIO positively regulated Notch signalling in DPSCs. (a) RT-PCR revealed 
differences in the expression of Notch mediators, ligands and receptors under BIO exposure. (b) qPCR 
analysis confirmed an increase in Notch 2, Jagged1, Wnt3, β-catenin and Hes1 expression between control 
(MBIO) and BIO conditions. Data were normalised to β-actin and Gapdh levels and presented as mean 
+ SEM (n = 4). The dashed line represented normalised gene expression in control conditions. (c,d) IF 
images of active N1ICD, in cells treated with BIO and MBIO. Scale bar = 20 µm (e) Bar chart showing 
relative total and nuclear N1ICD fluorescence in MBIO- and BIO-treated cells. (f) WB showing an increase 
in N1ICD expression in BIO-treated DPSCs. β-actin was used as a protein loading control. * p < 0.05, 
** p < 0.01, *** p < 0.001. U-Mann Whitney test.
in expression, except the Notch2 receptor, which was 
found to be slightly upregulated at the transcript 
level (Fig. 6a,b). However, the Notch canonical ligand 
Jagged1 underwent a much larger 8-fold increase in 
expression, when the DPSCs were exposed to BIO, 
followed by Wnt-3a and β-catenin with a ~5-fold 
increased expression (Fig. 6b). Moreover, Hes1 was 
also prominently upregulated, which constituted 
solid evidence that Notch signalling was being 
hyperactivated by BIO treatment (Fig. 6b). Notch 
signalling upregulation at the protein level was also 
tested, using an antibody for active cleaved N1ICD. 
Increased levels of N1ICD were detected for BIO-
treated DPSCs by both WB and IF (Fig. 6c-f).
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Wnt/Notch activation enhanced expression of 
neural crest markers in DPSCs
Notch/Wnt are crucial in NC induction and their 
activation enhanced core factor expression in 
DPSCs. Thus, it was important to test whether 
NC markers would also be affected by Notch/Wnt 
pharmacological modulation. It was found that 
both Snai1 and Snai2 were constitutively expressed 
in DPSCs, especially Snail/Snai1 (Fig. 7a,b). Other 
NC gene markers, such as Pax3, Neurogenin2, Twist1 
and Hnk1, were also expressed in control DPSCs. 
However, when DSPCs were cultured with DAPT, the 
expression of all these markers was downregulated to 
less than 50 % of the basal levels as assessed by qPCR, 
with Pax3 being downregulated to more than 90 % 
of its basal expression (Fig. 7a,b). Conversely, when 
cells were cultured with BIO, most markers showed 
a ~2-fold increased expression compared to control 
levels, with the notable exception of Pax3, which 
increased more than 10-fold (Fig. 7c,d). Some NC 
gene markers, which presented a very low expression 
in control DPSCs, such as Sox10, yielded consistent 
amplicon bands in conventional RT-PCR following 
BIO treatment. All these changes were corroborated 
by qPCR (Fig. 7c,d). Thus, Notch/Wnt activation 
upregulated the expression of both pluripotency and 
NC markers in DPSCs.
Wnt/Notch pre-activation enhanced 
differentiation of DPSCs to osteoblasts and 
adipocytes
Several in vitro protocols can be used to induce 
terminal differentiation of DPSCs to mature 
osteoblasts and adipocytes (Gronthos et al., 2002; 
Langenbach and Handschel, 2013). The working 
hypothesis was that a short (48 h) pre-activation of 
the Notch/Wnt signalling pathway would render 
DPSCs more responsive to differentiation signals. 
Conversely, Notch/Wnt pre-inhibition would result 
in a reduced DPSC differentiation capacity. To 
test this hypothesis, DPSCs were exposed to BIO 
or DAPT for 48 h. Untreated DPSCs were used 
Fig. 7. BIO and DAPT antagonistically regulated the expression of NC markers Snail/Snai1, Slug/Snai2, 
Sox10, Hnk1, Neurogenin2, Twist and Pax3 in DPSCs. (a) RT-PCR showing NC marker gene expression in 
DMSO and DAPT-treated DPSCs. (b) qPCR showing relative differences on Snai1, Snai2, Sox10, Hnk1, 
Neurogenin2, Twist and Pax3 expression. (c) RT-PCR showing NC markers gene expression in MBIO and 
BIO-treated DPSCs. (d) qPCR showing relative differences in Snai1, Snai2, Sox10, Neurogenin2, Twist and 
Pax3 expression. Data were normalised to β-actin and Gapdh levels and represented as mean + SEM (n = 3). 
The dashed line represented normalised gene expression in control conditions. * p < 0.05, ** p < 0.01, 
*** p < 0.001. U-Mann Whitney test.
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Fig. 8. A preconditioning exposure to BIO for 48 h enhanced DPSC differentiation efficiency into 
osteoblasts and adipocytes. (a-d) Alizarin Red S staining to assess calcified matrix formation and osteoblast 
differentiation in control (DMSO, MBIO), BIO and DAPT conditions. (e-h) ALP staining images at high 
magnification to detect osteoblastic commitment and differentiation in control (DMSO, MBIO), BIO 
and DAPT conditions. Scale bar = 100 µm. (i-l) Oil Red O staining to assess lipid droplet formation and 
adipocyte differentiation in control (DMSO, MBIO), BIO and DAPT conditions. Scale bar = 200 µm. (m) 
Relative absorbance quantification at 450 nm, 405 nm and 409 nm for Alizarin Red S, ALP and Oil Red 
O, respectively for DMSO- and DAPT-treated DPSCs. (n) Relative absorbance quantification at 450 nm, 
405 nm and 409 nm for Alizarin Red S, ALP and Oil Red O, respectively for MBIO and BIO conditions. 
Data were normalised to DMSO and MBIO as internal controls and presented as the mean + SEM (n = 6). 
* p < 0.05, ** p < 0.01, *** p < 0.001. U-Mann Whitney test.
as controls. Next, control and treated cells were 
exposed to osteoblastic differentiation medium in 
the absence of BIO or DAPT. To measure terminal 
osteoblastic differentiation, ALP and Alizarin Red 
S assays were used. Interestingly, after 3 weeks of 
osteogenic treatment, Alizarin Red S staining and 
calcified matrix deposit formation, as assessed by 
light absorbance, were between two- and three-
fold higher in the DPSCs pre-treated with BIO 
and significantly lower in DPSCs pre-treated with 
DAPT, when compared to controls (Fig. 8a-d,m). 
ALP enzymatic activity was also found to be 
significantly higher (i.e. osteoblastic differentiation 
more efficient) when DPSCs were pre-treated with 
BIO (Fig. 8e-h,m). To verify whether Notch/Wnt 
modulation could also affect DPSC differentiation 
into adipocytes, DPSCs were exposed to BIO or 
DAPT for 48 h. Control and treated cells were then 
exposed to adipogenic differentiation medium for 4 
weeks. Oil Red O staining was performed to assess 
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Fig. 9. Wnt activation by Wnt-3a increased the expression of pluripotency core factors, Notch markers 
and NC markers in DPSCs. (a) RT-PCR showing core factors (c-Myc, Sox2, Nanog, Oct4, Rex1, Stella and 
Ssea1), Hes1 and NC markers (Snai1, Snai2, Sox10, Hnk1, Neurogenin2, Twist and Pax3) expression in DPSCs 
treated with DMSO and 2.5 µM and 5 µM Wnt-3a.(b,c) qPCR showing relative differences in the expression 
of (b) the core factors c-Myc, Sox2, Nanog, Oct4, Rex1, Stella, Ssea1, Hes1, Lef1 and β-catenin and (c) the 
NC markers Snai1, Snai2, Sox10, Hnk1, Neurogenin2, Twist and Pax3. Data were normalised to β-actin and 
Gapdh levels and represented as the mean + SEM (n = 3). The dashed line represented normalised gene 
expression in control conditions. * p < 0.05, ** p < 0.01, *** p < 0.005. Dunn´s Test, Kruskall Wallis H Test.
adipocyte generation. Interestingly, it was found that 
BIO pre-treatment also enhanced DPSCs conversion 
to adipocytes as assessed by Oil Red O after the 
differentiation treatment period. Oil Red O staining 
was significantly higher in the BIO-pre-treated cells, 
near twice as much as controls (Fig. 8i-l,n).
Wnt activation by exposure to human 
recombinant Wnt-3a protein for 48 h enhanced 
the expression of NC and pluripotency core 
factors in DPSCs
Since BIO is known to be a general GSK3-β inhibitor 
(Meijer et al., 2003), BIO treatment could affect other 
signalling pathways apart from Wnt. To prove that 
the observed effects on the expression of core and NC 
factors and stemness of DPSCs depended specifically 
on the canonical Wnt signalling pathway, Wnt-3a 
protein was used, a well-described prototypical 
canonical Wnt ligand (Famili et al., 2015; Zhang 
et al., 2009), to stimulate DPSCs for 48 h in similar 
conditions to BIO treatment. Two concentrations of 
human recombinant Wnt-3a were used: 2.5 µM and 
5 µM, to verify any possible dose-dependent effects. 
Interestingly, pluripotency and NC factors showed 
increased expression when exposed to Wnt-3a, being 
the effect more pronounced at the concentration of 
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Fig. 10. Wnt activation 
by Wnt-3a upregulated 
Notch signalling in 
DPSCs. (a-i) IF images 
o f  D P S C s  g r o w n 
for 48 h in presence 
or absence of Wnt-
3a at two different 
concent ra t ions  o f 
2.5 µM and 5 µM and 
immunolabeled for 
(a-c) N1ICD, (d-f) total 
β-catenin (g-i) and 
Ki67. DAPI labelled 
cell nuclei in blue. 
Scale bar = 20 µm. (j) 
Bar charts showing 
relative total N1ICD 
and total β-catenin 
fluorescence in control 
and Wnt-3a-treated 
DPSCs. (k) Bar charts 
s h o w i n g  r e l a t i v e 
n u c l e a r  N 1 I C D , 
β-catenin and Ki67 
labelling fluorescence 
in control and Wnt-3a-
treated DPSCs. Data 
are presented as mean 
+ SEM (n = 3). * p < 0.05, 
** p < 0.01, *** p<0.001. 
Dunn´s Test, Kruskall 
Wallis H Test.
5 µM. Among the markers that were most strongly 
affected Sox2, Oct4 (Pou5f1 and Pou5f1p1), Lin28, 
Stella, Ssea1, Slug, Hnk1 and Sox10 were detected 
(all within a ~5-10-fold increase in expression) Pax3 
was also present (~30-fold increase with 5 µM Wnt-
3a). As a control for Wnt activation, Lef1 expression 
was solidly upregulated after Wnt-3a treatment. All 
expression changes were verified by RT-PCR and 
qPCR (Fig. 9a-c).
Exposure to Wnt-3a upregulated Notch/Wnt 
crosstalk signalling in DPSCs
Verification whether the Notch/Wnt interaction was 
also required, which was observed after DAPT/BIO 
treatments, and was also observed after treating 
cells with Wnt-3a. QPCR experiments had already 
showed a clear upregulation of Hes1 expression in 
DPSCs exposed to Wnt-3a (Fig. 9b). This result was 
corroborated by IF and a significantly increased 
N1ICD nuclear fluorescence was found, especially 
at a concentration of 5 µM Wnt-3a (Fig. 10a-c,k). 
Similarly, nuclear β-catenin protein labelling was also 
found to be increased (Fig. 10d-f,k). Finally, similar 
results were observed for Ki67 labelling levels (Fig. 
10g-I,k). Thus, 5 µM Wnt-3a induced a coordinated 
upregulation of Notch/Wnt cross-signalling and an 
increased proliferation capacity in DPSCs.
A preconditioning treatment with human 
recombinant Wnt-3a enhanced the differentiation 
capacity of DPSCs to osteoblasts and adipocytes
Finally, and in view of the previous results, verification 
was needed as to whether a preconditioning 
treatment with Wnt-3a would also render DPSCs 
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Fig. 11. A preconditioning 
t rea tment  wi th  Wnt -
3a for 48  h  enhanced 
DPSC d i f fe rent ia t ion 
efficiency into osteoblasts 
and adipocytes .  (a-c ) 
Alizarin Red S staining 
t o  a s s e s s  c a l c i f i e d 
matrix formation and 
osteoblast differentiation 
in control (DMSO) and 
W n t - 3 a  ( 2 . 5  µ M  a n d 
5 µM) conditions.  (d-
f) ALP staining images 
at high magnification 
to  detect  osteoblast ic 
l i n e a g e  c o m m i t m e n t 
and differentiation in 
control (DMSO) and Wnt-
3a (2.5 µM and 5 µM) 
conditions. (g-i) Oil Red 
O staining to assess lipid 
droplet formation and 
adipocyte differentiation 
in control (DMSO) and 
W n t - 3 a  ( 2 . 5  µ M  a n d 
5 µM) treatment. Scale 
bar = 200 µm (j) Relative 
absorbance quantification 
at 450 nm, 405 nm and 
409 nm for Alizarin Red 
S, ALP and Oil Red O, 
respectively. Data were 
normal ised to  DMSO 
as internal control and 
presented as mean + SEM 
(n = 4).* p < 0.05. Dunn´s 
Test, Kruskall Wallis H Test.
more responsive to osteogenic and adipogenic 
differentiation treatments. DPSCs were exposed to 
a preconditioning treatment with Wnt-3a for 48 h 
and subsequently cells were placed in osteogenic 
and adipogenic culture media, respectively – in 
similar conditions as shown before with DAPT/BIO. 
As predicted, pre-treatment with Wnt-3a enhanced 
the capacity of DPSCs to differentiate to osteoblasts 
and adipocytes (Fig. 11). The effect was more 
pronounced with 5 µM than with 2.5 µM Wnt-3a and 
was comparable to the one obtained with BIO (Fig. 
8), with an almost 3-fold increase in Alizarin Red 
S staining and near to 2-fold increase in Oil Red O 
staining compared to control, non-pre-treated DPSCs 
cultures (Fig. 11j).
Discussion
It was here reported for the first time that both Notch 
and Wnt signalling were required for the expression 
of NC and pluripotency core factors in DPSCs. 
Importantly, both pathways positively regulated each 
other in maintaining DPSC stemness and specific 
activation or inhibition of one pathway invariably 
affected the other in the same way. These findings 
shed light on the control mechanisms of DPSC 
self-renewal and maintenance and have important 
potential implications regarding the use of DPSCs 
for cell therapy.
 There are several reasons for the interest in DPSCs 
and other dental stem cells. These cells are easily 
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accessible in both young and aged patients, possess 
a significant capacity for in vitro expansion and 
have non-tumourigenic phenotypes. Furthermore, 
evidence shows that DPSCs have a greater multi-
lineage differentiation potential compared to other 
tissue-specific stem cells (Atari et al., 2012; Kerkis 
et al., 2006; Rosa et al., 2016). It is illustrative of 
the growing acknowledgement of the stemness 
potential of DPSCs that some authors have referred 
to some subpopulations of these cells as dental pulp 
pluripotent stem cells or DPPSCs (Atari et al., 2012).
 Arguably, induced pluripotent stem cells (iPSCs), 
derived from autologous somatic cells, could be 
regarded as the ideal source of stem cells for in vivo 
cell therapy. These cells are truly pluripotent (i.e. 
have no restriction to differentiate in any type of 
adult cell), can be extracted from any donor’s tissue 
and have the donor’s same genetic background. 
However, traditional cell reprogramming procedures 
rely on permanent gene transfection with Yamanaka 
or related core pluripotency factors (Takahashi 
et al., 2007) and, for safety reasons, this is not yet 
acceptable. Hence, while these cell reprogramming 
technologies are not mature enough for clinical use, 
the interest in searching for alternative sources of 
autologous pluripotent-like cells, including DPSCs, is 
growing very fast. The possibility to boost the natural 
pluripotency-like features of DPSCs by methods that 
do not involve permanent chromatin modification or 
gene transfection is highly desirable for cell therapy.
 Canonical Notch and Wnt signalling pathways 
are described as pivotal regulators of stemness and 
pluripotency (Clevers et al., 2014; Dravid et al., 2005; 
Fox et al., 2008; Li and Chen, 2012; Lluis et al., 2008; 
Lowell et al., 2006; Park et al., 2008; Simandi et al., 
2016; Yan et al., 2010) and their pharmacological 
manipulation has already been tested as a strategy 
to enhance either cell differentiation (Kitajima 
et al., 2016) or cell reprogramming (Ichida et al., 
2014). Notch inhibition by γ-secretase blockers is 
associated with an increased efficiency of keratinocyte 
reprogramming (Ichida et al., 2014). However, a very 
different effect was found in the studied model 
system with DCPSs: Notch inhibition by DAPT 
decreased the expression of core factors in DPSCs 
and diminished their capacity to generate fully 
differentiated osteoblasts and adipocytes. In this 
regard, it was worthy to note that Notch effects have 
long been known to be extremely context-dependent: 
the same Notch signal can have very different 
outcomes depending on the cell type, physiological 
state and extracellular environment. Regarding Wnt 
signalling, its pharmacological activation by GSK3-β 
inhibitors in mouse iPSCs is associated with increased 
cell differentiation (Kitajima et al., 2016). However, 
in the DPSC model, BIO application significantly 
increased the expression of core factors and enhanced 
DPSC differentiation potential towards adult 
osteoblasts and adipocytes. Again, these differences 
were attributed to the different cell culture systems 
that were tested in this and other studies.
 One important difference between the current 
study and the aforementioned studies was the 
presence/absence of serum in the culture medium. 
The use of medium containing FBS is well established 
as the gold standard for manipulation and in vitro 
expansion of DPSCs (Gronthos et al., 2002; Gronthos 
et al., 2000). In vitro expansion of DPSCs is often 
inevitable due to the small amounts of tissue material 
and total cell numbers that can be collected from the 
human dental pulp, as compared to other stem cell 
sources. In this regard, despite ongoing progress 
in culture media formulations that do not contain 
foetal serum for maintenance of DPSCs (Bonnamain 
et al., 2013; Eubanks et al., 2014; Jung et al., 2016; 
Xiao and Tsutsui, 2013), currently the addition of 
FBS or related agents to the culture media permits 
easily overcoming the issue of initial cell expansion. 
However, it is becoming increasingly apparent that 
FBS-containing media also induce differentiation of 
DPSCs into a default osteo/odontogenic pathway 
(Pisciotta et al., 2012; Yu et al., 2010) and this may not 
be the best choice to generate certain cell lineages, 
particularly neural cells, from DPSCs (Jung et al., 
2016). Moreover, upon continual expansion induced 
by the presence of 10 % FBS, DPSC cultures also tend 
to generate populations of committed/differentiated 
cells (Mokry et al., 2010). Therefore, progressive stem 
cell exhaustion was also a concern in this study. We 
confirmed that the proliferation rates and core factor 
expression decreased steadily in DPSCs upon serial 
passaging (data not shown). This correlation between 
sustained stem cell aging and loss of multipotency is 
also reported elsewhere (Bose and Shenoy, 2016).
 One important finding of this study was that Notch 
and Wnt pathways operated coordinately as part of 
a common network to maintain DPSC stemness. We 
found that the expression of core factors in DPSCs was 
completely dependent upon Notch/Wnt signalling. 
Notch inhibition by DAPT applications abolished 
the expression of core factors and decreased DPSC 
stemness. These results were accompanied by parallel 
Wnt inhibition. Conversely, Wnt activation by BIO or 
Wnt-3a significantly increased the expression of core 
factors and DPSC stemness. In view of this evidence, 
the question became what connection do these 
pathways have at the molecular level? Many positive 
and negative interactions are reported between both 
pathways in a myriad of model systems (Borggrefe 
et al., 2016; Fukunaga-Kalabis et al., 2015; Kwon et al., 
2011; Nicolas et al., 2003; Shi et al., 2015). In colorectal 
cancer cells, Wnt signalling affects Notch through 
β-catenin-mediated transcriptional activation of the 
gene Jagged1 (Rodilla et al., 2009). Jagged1 is a Notch 
ligand, which can activate Notch receptors and, 
consequently, Notch signalling. Consistently, BIO-
induced Wnt activation in DPSCs elicited a sharp 
increase in the transcriptional levels of Jagged1. It is 
likely that such an increased Jagged1 transcription 
would eventually activate Notch receptors in DPSCs 
cultures. In addition, β-catenin physically binds 
to and interacts with reprogramming factors, in 
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particular Oct4a (Simandi et al., 2016), whereas Oct4a 
transcription levels are also positively regulated by 
Wnt signalling in pluripotent stem cells (Li and Chen, 
2012; Simandi et al., 2016). Finally, Wnt/β-catenin 
also increases c-Myc transcription, which promotes 
cell proliferation (Barker et al., 2000). Consistently, 
DPSCs treated with BIO or Wnt-3a showed an 
increased transcription of c-Myc, which was related 
to an increased cell proliferation.
 Together with enhanced core factor expression, 
activation of the Notch/Wnt signalling pathways 
also increased the expression of NC markers in 
DPSCs. Both Notch and Wnt signals are associated 
with NC induction (Gazarian and Ramirez-Garcia, 
2017; Hari et al., 2012; Leung et al., 2016; Rogers et al., 
2012; Stuhlmiller and Garcia-Castro, 2012). Indeed, 
NC cells also express relatively high levels of core 
factors, which possibly relates to their ample capacity 
to generate very diverse cell lineages (Thomas et 
al., 2008). It was found that the NC markers Pax3, 
Hnk1, Twist, Neurogenin2, Snail/Snai1, Slug/Snai2 
and Sox10 had increased expression levels when the 
DPSCs were exposed to Wnt-3a or BIO and that their 
expression decreased in the presence of DAPT, thus 
showing a similar relationship to the one found with 
pluripotency core factors.
 The results demonstrated that Wnt/Notch 
activation increased DPSC stemness. This could have 
important implications for optimising the clinical 
use of these cells. A short preconditioning treatment 
with Wnt-3a or BIO for 48 h was enough to improve 
the potential of DPSC to differentiate into at least 
two different adult cell lineages, osteoblasts and 
adipocytes, which are both of mesenchymal origin. 
This very important finding proved that DPSC 
exhaustion by continuous exposure to FBS could be 
at least partially prevented by transiently boosting 
the activity of Notch/Wnt pathways, by means of 
small molecules and/or recombinant proteins, which 
would enhance stemness traits of DPSC cultures just 
48 h before use for differentiation or cell transplant. 
It would also be very interesting to verify whether 
such preconditioning would also be effective for other 
non-mesenchymal cell lineages of interest, such as 
Schwann cells (Martens et al., 2014), neuron-like cells 
(Gervois et al., 2015) and hepatocyte-like cells (Atari et 
al., 2012). Finally, the adoption of this preconditioning 
strategy could also be applicable to differentiation 
protocols that do not rely on FBS (Eubanks et al., 
2014; Xiao and Tsutsui, 2013), allowing for a faster 
translation to clinical therapy.
Conclusions
Our data showed that Notch and Wnt signalling 
were required for the maintenance of NC and 
core pluripotency factor expression in DPSCs. 
Furthermore, both pathways operated coordinately 
as part of the same signalling network to maintain 
DPSC stemness. Thus, a 48 h Notch/Wnt signalling 
activation preconditioning step by BIO or Wnt-3a 
significantly enhanced the capacity of DPSCs to 
respond to standard in vitro protocols for osteoblastic 
and adipogenic differentiation. Conversely, Notch/
Wnt inhibition decreased DPSC stemness. These 
preconditioning changes involved levels of expression 
of core pluripotency and NC factors, which correlated 
with an enhanced differentiation potential of DPSCs. 
This strategy could be used alone or in conjunction 
with other cell reprogramming methods that 
do not involve permanent gene transduction or 
modifications at genome level to generate DPSCs and 
other tissue-specific adult stem cells with increased 
self-renewal and cell differentiation potential for cell 
therapy.
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Discussion with Reviewers
Benjamin  Fournier :  Do you think that the 
supplements you used in this study (especially BIO) 
may become part of the serum replacement strategy, 
when growing DPSC? Did you experiment (or did 
you plan to experiment) the use of these factors on 
other stem cells?
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Authors: The main advantage of the use of FBS 
is that it permits a very rapid amplification of the 
collected cells for various uses (e.g. cell therapy). This 
is particularly important for the dental pulp where 
the starting collected material is usually very small, 
compared to other stem cell sources. However, the 
downside is that upon continuous amplification, stem 
cell populations tend to exhaust (i.e. lose proliferation 
and multilineage differentiation capacity). One 
important implication of this work was that DPSC 
exhaustion by continuous exposure to FBS could be at 
least partially prevented by transiently boosting, just 
48 h before use, the activity of Notch/Wnt pathways 
– by means of small molecules and/or recombinant 
proteins – which would enhance stemness traits of 
DPSCs cultures for in vitro differentiation. We really 
do not think that these treatments alone could work 
as a serum replacement strategy, but rather as a 
complementary mechanism to prevent stem cell 
exhaustion after several rounds of culture passaging. 
We do not plan to extend these experiments to other 
stem cell sources yet, but we think it would be a very 
interesting idea.
Marco Tatullo: Authors have clearly reported how 
the potency of DPSCs can be enhanced by short 
preconditioning treatments with Wnt activators. Is 
it reasonable to consider such treatments as part of 
a functionalised scaffold to be used in a specific site 
to aid regeneration?
Authors: We definitely think this is a very interesting 
idea, especially for Wnt-3a, which is an extracellular 
water-soluble protein and could be easily incorporated 
into a functionalised scaffold by a team expert in 
biomaterials research.
Editor note: The scientific editor for this paper was 
Christine Hartmann.
